Melvin Parasram, DO, MS

Neurointensivist 🧠 @nyphospital Queens | Assistant Professor of Clinical Neurology @WCMCneurology | Bx 🙅🏾‍♂️ 🗽| 🇬🇾 |#GirlDadx2

[NEW YORK KNICKS @nyknicks]

THE PLAY THAT PUT THE KNICKS UP 3-1.

[Melvin Parasram, DO, MS @mel_para]

I’m proud to share that I’ve been selected as a Stony Brook University 40 Under Forty honoree for 2026! I am honored and grateful!

Once a Seawolf, always a Seawolf! #SBU40Under40

See who's joining me as a 40 Under Forty honoree: https://t.co/keCOARGLy8

[Stony Brook Alumni @stonybrookalum]

Congratulations to @stonybrooku's 2026 40 Under Forty honorees!

These exceptional alumni are leading with purpose, driving innovation and making an impact in their professions and communities. #SBU40Under40

Meet the 40 alumni who are shaping the future: https://t.co/uvv6ifE89w

[Mica Schachter, MD @neurona_critica]

Thrombectomy for Cerebral Venous Sinus Thrombosis: A Nationwide Analysis of Outcomes

https://t.co/gFu1ASYohq

@svinsociety

[Melvin Parasram, DO, MS @mel_para]

Congratulations to my brother on receiving this prestigious award! I am very proud! @Mp_Chemist @ParasramLab

[The Camille and Henry Dreyfus Foundation @dreyfusfndn]

Congratulations to Dr. Marvin Parasram (@Mp_Chemist), @nyuniversity, for being named a 2025 Camille Dreyfus Teacher-Scholar! @ParasramLab @nyuchemistry #DreyfusAwards

[Melvin Parasram, DO, MS @mel_para]

Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial - The Lancet Neurology https://t.co/WRe76f3uuA

[Melvin Parasram, DO, MS @mel_para]

The Last Conversation https://t.co/Ks2omv5iOD

[Hillary Clinton @HillaryClinton]

Before the election, I warned that there is no safe haven under authoritarianism.

If they can ship Kilmar Abrego Garcia to a foreign prison—accused of no crime, with no trial—they can do it to anyone.

Americans of conscience must stand against this now.

[Barack Obama @BarackObama]

Harvard has set an example for other higher-ed institutions – rejecting an unlawful and ham-handed attempt to stifle academic freedom, while taking concrete steps to make sure all students at Harvard can benefit from an environment of intellectual inquiry, rigorous debate and mutual respect. Let’s hope other institutions follow suit.

[Barack Obama @BarackObama]

Congratulations to Judge Susan Crawford on her victory, and to the people of Wisconsin for electing a judge who believes in the rule of law and protecting our freedoms.

[Bryan Carmody @jbcarmody]

Overall Match rates for IMGs are lower (68% for US citizen and 58% for non-US citizen IMGs).

Among IMGs, US citizens seem to be preferred in EM and FM, while non-US citizens made up relatively larger portions of matched pathology and neurology applicants.

[Bryan Carmody @jbcarmody]

Although graduating MD and DO students matched at nearly identical rates (93.5% vs. 92.6% in the 2025 NRMP Match), they matched into a different distribution of specialties.

[Melvin Parasram, DO, MS @mel_para]

She is an American doctor. This is out of control.

[Dr. Nemani @NemaniSonia]

Sir respectfully, I’m a born and raised American citizen.
Everyday I have and will continue to dedicate my life to the health and well being of our people and communities.

[Melvin Parasram, DO, MS @mel_para]

Let's harness the unstoppable power of our Stony Brook community to achieve extraordinary things. #SBUGivingDay https://t.co/vrOg667w1N

[Stroke AHA/ASA @StrokeAHA_ASA]

🧵In a meta-analysis of randomized controlled trials that enrolled patients with acute ischemic stroke beyond 4.5 hours of time last known well, administration of thrombolysis (compared with placebo) led to a higher odds of a good functional outcome despite a higher odds of sICH.

[Melvin Parasram, DO, MS @mel_para]

Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial - The Lancet https://t.co/UKAP1S8wOm

[Zach London @zach_london]

For those of you matching into neurology this week:
Congratulations and welcome to the family!

(Shhh. Don’t let the rest of them know we have a secret handshake!) @NMatch2025

[Oren Gottfried, MD @OGdukeneurosurg]

Great mri brain anatomy by @teachplaygrub

[Samuel Hume @DrSamuelBHume]

Top 5 advances in medicine in February (🧵)

1. The first large trial to show that oxygen can improve outcomes in stroke

Patients in this trial had acute ischaemic stroke (caused by a large vessel blockage in the front part of the brain)

They received either 100% oxygen at 10 litres/minute (via a non-rebreather mask), or a sham treatment (roughly equivalent to breathing oxygen from air), for 4 hours

All patients were treated with thrombectomy (mechanical clot removal), and that's the key: it's thought that oxygen 'freezes' the penumbra (the salvageable brain tissue) before blood flow is restored by thrombectomy

That also explains why this hasn't been found before: previous trials were done before thrombectomy was widely used

This trial was done in only one country, in a select group of patients, so we'll need broader trials: these are underway

https://t.co/Y0gr6RAV5B

[MaxMokinMD @MokinMax]

Practical recommendations on selection of patients with large infarct for thrombectomy from @svinsociety @SVINJournal

Keeping it simple approach minimizes delays to treatment

⌛️= 🧠

https://t.co/m7T5LTA40Y